Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2020 08:00 ET | Source: Orchestra BioMed

Orchestra BioMed™ Adds Seasoned Biotech Executive Pamela Yanchik Connealy to Board of Directors

Ms. Yanchik Connealy will serve as the Audit Committee Chair, strengthening Orchestra BioMed’s financial reporting capabilities NEW HOPE, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Orchestra BioMed,...
December 10, 2019 08:00 ET | Source: Orchestra BioMed

Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank

NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in...
December 05, 2019 08:00 ET | Source: Orchestra BioMed

Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI Focus D-HF Congress

NEW HOPE, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs...
November 19, 2019 07:30 ET | Source: Orchestra BioMed

Orchestra BioMed™ to Present at the Canaccord Genuity MedTech and Diagnostics Forum and the 31st Annual Piper Jaffray Healthcare Conference

NEW HOPE, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs...
October 16, 2019 07:30 ET | Source: Orchestra BioMed

Orchestra BioMed™ Strengthens Management Team with Appointments of Expert Product Development Leaders Juan A. Lorenzo and Paul V. Goode, Ph.D.

NEW HOPE, Pa., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs...
September 28, 2019 15:45 ET | Source: Orchestra BioMed

Orchestra BioMed Announces Late-Breaking Clinical Results Showing BackBeat Cardiac Neuromodulation Therapy™ Drives Significant Reduction in Systolic Blood Pressure

Double-blind, randomized trial data demonstrates clinically meaningful and statistically significant difference of 8.1 mmHg in reduction of 24-hour ambulatory systolic blood pressure at 6 months vs....
September 17, 2019 07:30 ET | Source: Orchestra BioMed

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease

First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease Follows Breakthrough Device designation for Virtue...
September 04, 2019 07:30 ET | Source: Orchestra BioMed

Orchestra BioMed Receives CE Mark for BackBeat Cardiac Neuromodulation Therapy™ (CNT) for Hypertension

NEW HOPE, Pa., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet...
August 27, 2019 07:30 ET | Source: Orchestra BioMed

Orchestra BioMed™ Appoints Dennis Donohoe, M.D., Leading Clinical Development Expert, as Chief Medical Officer

NEW HOPE, Pa., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs...
July 10, 2019 07:30 ET | Source: Orchestra BioMed

Orchestra BioMed™ Completes $34 Million Financing to Accelerate Product Pipeline Development and Advance Partnerships

Series B-1 Round Led by Perceptive, RTW and Soleus Capital with Strategic Participation from Terumo Corporation Secures $64 Million in 2019 Capital Inflows, Including $30 Million Upfront Payment from...